- Home
- BME vs PRME Comparison
BME vs PRME Comparison
Compare BME & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BME | PRME |
|---|---|---|
| Founded | N/A | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 503.7M | 666.1M |
| IPO Year | 2005 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BME | PRME |
|---|---|---|
| Price | $38.98 | $2.99 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $7.56 |
| AVG Volume (30 Days) | 50.8K | ★ 2.0M |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,632,000.00 |
| Revenue This Year | N/A | $7.06 |
| Revenue Next Year | N/A | $47.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $35.03 | $1.11 |
| 52 Week High | $42.74 | $6.94 |
Technical Indicators
Market Signals| Indicator | BME | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 44.45 | 32.92 |
| Support Level | $37.71 | N/A |
| Resistance Level | $39.52 | $3.97 |
| Average True Range (ATR) | 0.48 | 0.23 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 39.87 | 1.21 |
Price Performance
Historical ComparisonAbout BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.